Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients
出版年份 2015 全文链接
标题
Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients
作者
关键词
MicroRNAs, Hepatocellular carcinoma, Fibrosis, Biomarkers, Cirrhosis, Diagnostic medicine, Hepatitis C virus, Liver fibrosis
出版物
PLoS One
Volume 10, Issue 9, Pages e0137706
出版商
Public Library of Science (PLoS)
发表日期
2015-09-10
DOI
10.1371/journal.pone.0137706
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression
- (2015) Xiaoxia Sun et al. CELL CYCLE
- microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma
- (2015) Zheng Zhang et al. Molecular Cancer
- Serum Interferon-Related MicroRNAs as Biomarkers to Predict the Response to Interferon Therapy in Chronic Hepatitis C Genotype 4
- (2015) Tarek Kamal Motawi et al. PLoS One
- A Serum MicroRNA Panel as Potential Biomarkers for Hepatocellular Carcinoma Related with Hepatitis B Virus
- (2014) Youwen Tan et al. PLoS One
- Association of Serum MicroRNA Expression in Hepatocellular Carcinomas Treated with Transarterial Chemoembolization and Patient Survival
- (2014) Mei Liu et al. PLoS One
- Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease
- (2014) Davide Povero et al. PLoS One
- HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
- (2013) A M Attallah et al. BRITISH JOURNAL OF CANCER
- Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia
- (2013) Amal A. Abd-El-Fattah et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression
- (2013) Shubham Shrivastava et al. HEPATOLOGY
- Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis
- (2013) Sharon Pok et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference
- (2013) A. Hatzakis et al. JOURNAL OF VIRAL HEPATITIS
- Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues
- (2013) Minhua Rong et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors
- (2013) Hiroshi Matsumura WORLD JOURNAL OF GASTROENTEROLOGY
- An Integrative Meta-analysis of MicroRNAs in Hepatocellular Carcinoma
- (2013) Mahmoud ElHefnawi et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma
- (2012) Florie Borel et al. JOURNAL OF HEPATOLOGY
- Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis
- (2012) Jonel Trebicka et al. JOURNAL OF HEPATOLOGY
- MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway
- (2012) Jie Xu et al. LIVER INTERNATIONAL
- Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation
- (2012) Zhong-Bo Han et al. Molecular Oncology
- Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study
- (2012) Angela M Liu et al. BMJ Open
- Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma
- (2011) Kevin Z. Qu et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
- (2011) Jian Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
- (2011) Yoshito Tomimaru et al. JOURNAL OF HEPATOLOGY
- Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
- (2011) Andreas Karakatsanis et al. MOLECULAR CARCINOGENESIS
- MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region
- (2011) A.-r. Yoon et al. NUCLEIC ACIDS RESEARCH
- miR-296 regulation of a cell polarity–cell plasticity module controls tumor progression
- (2011) V Vaira et al. ONCOGENE
- Sequencing and Bioinformatics-Based Analyses of the microRNA Transcriptome in Hepatitis B–Related Hepatocellular Carcinoma
- (2011) Yoshiaki Mizuguchi et al. PLoS One
- Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
- (2011) Silvia Cermelli et al. PLoS One
- Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
- (2011) Peng Qi et al. PLoS One
- NF- B dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies
- (2011) J. L. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of microRNAs in liver cancer progression
- (2010) S Huang et al. BRITISH JOURNAL OF CANCER
- Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes
- (2010) C. Braconi et al. CLINICAL CANCER RESEARCH
- Serum microRNA characterization identifiesmiR-885-5pas a potential marker for detecting liver pathologies
- (2010) Junhao Gui et al. CLINICAL SCIENCE
- Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
- (2010) Jian Xu et al. MOLECULAR CARCINOGENESIS
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
- (2009) Janaiah Kota et al. CELL
- AngiomiRs—Key regulators of angiogenesis
- (2009) Shusheng Wang et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways
- (2009) Can-Jie Guo et al. FEBS Journal
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
- (2009) Jorge A. Marrero et al. GASTROENTEROLOGY
- MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells
- (2009) Teng Xu et al. HEPATOLOGY
- Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated
- (2009) Xiao-Hui Huang et al. HEPATOLOGY RESEARCH
- miR-221 overexpression contributes to liver tumorigenesis
- (2009) P. Pineau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating microRNAs, potential biomarkers for drug-induced liver injury
- (2009) K. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-296 Regulates Growth Factor Receptor Overexpression in Angiogenic Endothelial Cells
- (2008) Thomas Würdinger et al. CANCER CELL
- p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest
- (2008) C. J. Braun et al. CANCER RESEARCH
- Diagnosis and Treatment of Hepatocellular Carcinoma
- (2008) Hashem B. El-Serag et al. GASTROENTEROLOGY
- Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
- (2008) Anna S. Lok et al. GASTROENTEROLOGY
- Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma
- (2008) Shunsuke Ura et al. HEPATOLOGY
- Down-regulation of the microRNAsmiR-34a,miR-127, andmiR-200bin rat liver during hepatocarcinogenesis induced by a methyl-deficient diet
- (2008) Volodymyr P. Tryndyak et al. MOLECULAR CARCINOGENESIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started